Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 13.72M | $73.0M | 15.17% | +2.82M | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 10.12M | $53.0M | 11.19% | -- | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 6.48M | $34.0M | 7.16% | -- | 2026-06-30 |
| Soleus Capital Management, L.P. | 3.38M | $18.0M | 3.73% | -- | 2026-06-30 |
| Kynam Capital Management, LP | 2.42M | $12.0M | 2.67% | +822.5K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.01M | $10.0M | 2.22% | +779.0K | 2026-06-30 |
| BlackRock, Inc. | 1.80M | $9.0M | 1.99% | +1.48M | 2026-06-30 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.02M | $5.0M | 1.13% | +461.5K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 993.4K | $5.0M | 1.10% | -- | 2026-06-30 |
| ADAR1 Capital Management, LLC | 900.9K | $4.0M | 1.00% | +748.1K | 2026-06-30 |
